Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Alkermes Plc (NQ: ALKS )

22.00 USD -0.01 (-0.05%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 7, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,003,267
Open 22.07
Bid (Size) 21.95 (1)
Ask (Size) 22.63 (1)
Prev. Close 22.01
Today's Range 21.94 - 22.49
52wk Range 14.52 - 23.92
Shares Outstanding 160,451,949
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Alkermes to Take Part in the BofA Securities 2021 Virtual Healthcare Conference
Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a virtual fireside chat at the BofA Securities 2021 Healthcare Conference on Wednesday, May 12, 2021 at 2:45 p.m. ET... 
From PR Newswire
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
Tags Events, Media & Communications Bipolar I Disorder Stakeholder Engagement
From 3BL Media: Corporate Social Responsibility, Energy and Health News

Performance

YTD
+11.45%
+11.45%
1 Month
+15.67%
+15.67%
3 Month
-4.51%
-4.51%
6 Month
+22.84%
+22.84%
1 Year
+40.40%
+40.40%

More News

Read More
Alkermes to Showcase Data From Psychiatry Portfolio at Upcoming Scientific Conferences Throughout Mental Health Awareness Month
From PR Newswire
Alkermes Announces Agreement with Sarissa Capital
From PR Newswire
Alkermes Launches New Disease State Website to Offer Education About Alcohol Dependence
Tags NASDAQ:ALKS Improving Healthcare Access Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Alkermes Announces Two Abstracts Accepted for Presentation at 2021 American Society of Clinical Oncology Annual Meeting
From PR Newswire
Alkermes plc Reports First Quarter 2021 Financial Results
From PR Newswire
Alkermes Launches New Disease State Website to Offer Education About Alcohol Dependence
From PR Newswire
Alkermes Initiates ARTISTRY-6 Trial of Nemvaleukin Alfa Monotherapy in Patients With Melanoma
From PR Newswire
Alkermes Supports Mental Health Clinical Research
Tags Health & Healthcare Improving Healthcare Access Pharma News, Research & Solutions
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Are You Thinking About Your Alcohol Drinking Habits?
Tags Wellness Events, Media & Communications NASDAQ:ALKS
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.